0,953  0,002  CYP2C9 substrate
0,946  0,003  Teratogen
0,946  0,003  Embryotoxic
0,944  0,002  Androgen antagonist
0,942  0,003  TNF expression inhibitor
0,922  0,005  Antiinflammatory
0,914  0,003  UDP-glucuronosyltransferase substrate
0,912  0,004  Respiratory analeptic
0,911  0,004  CYP2D6 substrate
0,911  0,004  Carcinogenic
0,900  0,002  Sulfotransferase substrate
0,898  0,004  CYP3A4 substrate
0,888  0,004  CYP2C19 substrate
0,881  0,003  Sensitization
0,865  0,003  NOS3 expression inhibitor
0,833  0,004  Analeptic
0,830  0,005  Antiallergic
0,833  0,011  Transcription factor NF kappa B inhibitor
0,823  0,002  UGT1A4 substrate
0,823  0,003  Endometrios treatment
0,820  0,001  UGT2B7 substrate
0,816  0,006  Antihypercholesterolemic
0,811  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,808  0,004  AR expression inhibitor
0,802  0,001  Progesterone antagonist
0,778  0,002  Contraceptive
0,775  0,001  UGT2B15 substrate
0,763  0,004  CYP2C19 inhibitor
0,762  0,004  CTGF expression inhibitor
0,754  0,001  UGT2B4 substrate
0,750  0,001  Antipruritic, allergic
0,751  0,005  UGT1A9 substrate
0,740  0,003  Prostatic (benign) hyperplasia treatment
0,730  0,001  Lipocortins synthesis antagonist
0,729  0,003  Hair growth stimulant
0,726  0,002  Aromatase inhibitor
0,724  0,001  Contraceptive female
0,725  0,002  Postmenopausal disorders treatment
0,721  0,003  Anesthetic general
0,714  0,008  Mutagenic
0,710  0,007  Cholesterol antagonist
0,724  0,021  Caspase 9 stimulant
0,707  0,008  Aldehyde oxidase inhibitor
0,704  0,006  NOS2 expression inhibitor
0,692  0,004  Diuretic
0,684  0,000  Transcortin receptor antagonist
0,694  0,010  Prostate cancer treatment
0,690  0,009  CYP1A2 substrate
0,710  0,029  Apoptosis agonist
0,683  0,003  Antipruritic
0,683  0,007  Antiosteoporotic
0,683  0,007  Eye irritation, high
0,678  0,001  Glucocorticoid antagonist
0,681  0,008  Bone diseases treatment
0,665  0,001  Androgen agonist
0,663  0,008  Proliferative diseases treatment
0,655  0,001  Aldosterone antagonist
0,656  0,007  Immunosuppressant
0,652  0,004  Anesthetic
0,653  0,008  Cardiovascular analeptic
0,665  0,025  Antineoplastic (breast cancer)
0,642  0,002  Contraceptive male
0,628  0,002  Abortion inducer
0,628  0,003  Estrogen receptor alpha antagonist
0,621  0,001  UGT2B9 substrate
0,618  0,005  Carcinogenic, group 3
0,610  0,002  Interferon gamma antagonist
0,607  0,002  Menstruation disorders treatment
0,597  0,001  Progesterone agonist
0,593  0,000  UGT2B11 substrate
0,585  0,001  Antipruritic, non-allergic
0,586  0,004  Antiacne
0,576  0,004  Psychosexual dysfunction treatment
0,567  0,007  UGT1A1 substrate
0,560  0,004  Muscular dystrophy treatment
0,555  0,005  P-glycoprotein inhibitor
0,557  0,010  UGT1A6 substrate
0,540  0,003  Prostate disorders treatment
0,534  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,543  0,016  Chemopreventive
0,537  0,011  Skin irritative effect
0,530  0,018  Antiepileptic
0,521  0,010  CYP3A4 inhibitor
0,515  0,004  Toxic, respiratory center
0,508  0,003  Cushing's syndrome treatment
0,504  0,001  5-Alpha-reductase 1 inhibitor
0,498  0,001  Glucocorticoid agonist
0,500  0,004  Estrogen agonist
0,497  0,004  Estrogen antagonist
0,491  0,003  Mineralocorticoid receptor antagonist
0,507  0,020  Cytostatic
0,490  0,005  NOS3 expression enhancer
0,489  0,004  Sodium/bile acid cotransporter inhibitor
0,484  0,002  Estradiol 17 beta-dehydrogenase inhibitor
0,484  0,003  Antineoplastic, alkylator
0,482  0,004  Antieczematic
0,502  0,024  Cytotoxic
0,473  0,001  5-Alpha-reductase inhibitor
0,470  0,004  Antiinfertility, female
0,457  0,005  UGT2B1 substrate
0,454  0,005  Antialcoholic
0,467  0,032  Inflammatory Bowel disease treatment
0,432  0,002  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,432  0,005  Carcinogenic, group 2B
0,451  0,028  Antineoplastic (pancreatic cancer)
0,432  0,009  Genotoxic
0,446  0,024  ICAM1 expression inhibitor
0,454  0,034  Antineoplastic (ovarian cancer)
0,421  0,001  RNA-directed RNA polymerase stimulant
0,419  0,002  UGT2B10 substrate
0,427  0,010  Melanin inhibitor
0,415  0,001  Postcoital contraceptive
0,418  0,006  Interleukin 6 antagonist
0,427  0,020  Interleukin 2 agonist
0,397  0,001  5-Alpha-reductase 2 inhibitor
0,395  0,000  Arachidonic acid antagonist
0,398  0,004  Interleukin 8 antagonist
0,395  0,003  SULT1A1 substrate
0,435  0,043  CYP2C9 inhibitor
0,392  0,003  Growth stimulant
0,407  0,021  Acute neurologic disorders treatment
0,409  0,025  Nitric oxide antagonist
0,389  0,005  Autism spectrum disorders treatment
0,448  0,072  Antiarthritic
0,372  0,007  Neurotrophic factor enhancer
0,370  0,006  Cholesterol synthesis inhibitor
0,388  0,026  Antineoplastic (renal cancer)
0,415  0,056  Antiasthmatic
0,364  0,006  Antifungal enhancer
0,410  0,060  Antileukemic
0,378  0,033  DNA damaging
0,348  0,005  LDLR expression enhancer
0,382  0,040  Antineoplastic (glioma)
0,348  0,008  Antihyperlipoproteinemic
0,370  0,031  Antidiabetic symptomatic
0,341  0,003  Estrogen receptor alpha agonist
0,349  0,013  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,380  0,044  Antineoplastic (melanoma)
0,353  0,018  Antihypotensive
0,424  0,092  Antineoplastic (solid tumors)
0,336  0,005  Estrogen receptor beta antagonist
0,328  0,001  Anabolic
0,356  0,029  DNA synthesis inhibitor
0,328  0,002  Premenstrual syndrome treatment
0,328  0,004  Estrogen receptor beta agonist
0,354  0,033  Antineoplastic (liver cancer)
0,335  0,014  Lipid peroxidase inhibitor
0,356  0,043  Chemoprotective
0,377  0,065  Stroke treatment
0,356  0,045  Antioxidant
0,328  0,017  UGT1A3 substrate
0,380  0,070  Antineoplastic (lung cancer)
0,313  0,005  Alcohol dehydrogenase substrate
0,306  0,005  Farnesoid X receptor antagonist
0,372  0,071  Toll-Like receptor 7 agonist
0,319  0,019  Diabetic retinopathy treatment
0,344  0,047  Antineoplastic (cervical cancer)
0,298  0,005  Age-related macular degeneration treatment
0,348  0,056  Apoptosis antagonist
0,296  0,004  Posttraumatic stress disorder treatment
0,331  0,039  Antineoplastic (glioblastoma multiforme)
0,349  0,060  Hepatic disorders treatment
0,311  0,023  VCAM1 expression inhibitor
0,364  0,076  Toll-Like receptor agonist
0,332  0,049  Antineoplastic (osteosarcoma)
0,338  0,055  Radioprotector
0,288  0,007  Phobic disorders treatment
0,324  0,043  Interleukin antagonist
0,322  0,050  Antihypoxic
0,322  0,051  Antineoplastic (endocrine cancer)
0,267  0,003  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,283  0,020  Monophenol monooxygenase inhibitor
0,274  0,014  Alkylator
0,254  0,004  SULT1E1 substrate
0,283  0,035  Hepatoprotectant
0,254  0,012  VEGF expression inhibitor
0,315  0,074  Immunostimulant
0,255  0,016  DNA polymerase I inhibitor
0,243  0,011  Antiprotozoal (Trichomonas)
0,249  0,017  Aldose reductase substrate
0,302  0,076  Antipsoriatic
0,281  0,056  Antineoplastic (lymphoma)
0,276  0,059  Angiogenesis stimulant
0,297  0,082  Antineoplastic (brain cancer)
0,232  0,021  Glutathione S-transferase substrate
0,211  0,005  Dysmenorrhea treatment
0,290  0,085  Antifungal
0,262  0,059  Antineoplastic (sarcoma)
0,220  0,018  Antineoplastic antibiotic
0,206  0,005  Toll-Like receptor 4 antagonist
0,204  0,006  Tocolytic
0,265  0,068  Interleukin agonist
0,197  0,001  Lipocortins synthesis agonist
0,199  0,004  Glycine receptor antagonist
0,246  0,051  Sedative
0,194  0,004  Glycine receptor agonist
0,212  0,026  Antirickettsial
0,197  0,011  Pregnane X receptor agonist
0,200  0,017  Choleretic
0,250  0,068  Cardiodepressant
0,233  0,054  Antiviral (Influenza)
0,179  0,001  Corticosteroid-like
0,174  0,003  Hypogonadism treatment
0,174  0,004  Anticholelithogenic
0,171  0,003  Estrone sulfatase inhibitor
0,165  0,004  Antihyperaldosteronism
0,203  0,042  Antiviral (Influenza A)
0,181  0,022  Coagulant
0,296  0,138  Antibacterial
0,157  0,002  SULT2A1 substrate
0,206  0,052  Antimutagenic
0,157  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,190  0,038  Allergic rhinitis treatment
0,205  0,053  Muscle relaxant
0,249  0,099  GST M1-1 substrate
0,153  0,010  Ornithine decarboxylase inhibitor
0,148  0,006  Na+ K+ transporting ATPase inhibitor
0,175  0,035  Aldehyde dehydrogenase inhibitor
0,140  0,002  Glucose-6-phosphate dehydrogenase inhibitor
0,161  0,024  Antineoplastic alkaloid
0,235  0,098  Gastrin inhibitor
0,205  0,070  Pneumotoxic
0,221  0,088  Antiprotozoal (Leishmania)
0,163  0,031  Microtubule formation inhibitor
0,141  0,009  Bile acid receptor antagonist
0,152  0,020  Actinic keratosis treatment
0,197  0,066  Growth factor agonist
0,152  0,021  Prolactin inhibitor
0,192  0,062  Macular degeneration treatment
0,167  0,038  Antiviral (Hepatitis B)
0,156  0,029  Ca2+-transporting ATPase inhibitor
0,240  0,121  Caspase 3 stimulant
0,118  0,001  Progesterone receptor A antagonist
0,116  0,003  Pregnane X receptor antagonist
0,155  0,042  Antihemorrhagic
0,153  0,043  Adenylate cyclase inhibitor
0,160  0,053  Antianemic
0,202  0,097  RNA-directed DNA polymerase inhibitor
0,144  0,041  Antineoplastic (uterine cancer)
0,220  0,120  Antineoplastic (colorectal cancer)
0,137  0,037  AMP-activated protein kinase stimulant
0,213  0,114  Antineoplastic (colon cancer)
0,158  0,060  Amylase inhibitor
0,217  0,122  5 Hydroxytryptamine uptake stimulant
0,153  0,058  Adenylate cyclase stimulant
0,117  0,026  Inducible nitric-oxide synthase inhibitor
0,214  0,124  Radiosensitizer
0,167  0,077  Phospholipase C inhibitor
0,188  0,098  Antineoplastic enhancer
0,097  0,008  Heme oxygenase stimulant
0,178  0,089  Non-steroidal antiinflammatory agent
0,119  0,040  Hedgehog signaling inhibitor
0,143  0,065  Bone formation stimulant
0,086  0,011  Potassium channel Kv1.3 blocker
0,179  0,105  Antiparkinsonian, rigidity relieving
0,098  0,026  SULT1A2 substrate
0,076  0,005  GABA uptake inhibitor
0,110  0,039  ABCA1 expression enhancer
0,100  0,030  Keratolytic
0,087  0,017  Nitric oxide donor
0,120  0,053  Rhinitis treatment
0,071  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,082  0,017  Andropause treatment
0,093  0,030  Narcotic antagonist
0,165  0,104  Psychostimulant
0,094  0,034  Estrogen-related receptor beta agonist
0,134  0,075  Neurotrophic factor
0,097  0,037  Antiprotozoal activity enhancer
0,183  0,124  Antipyretic
0,144  0,085  Movement disorders treatment
0,210  0,152  Immunomodulator
0,109  0,053  Anticataract
0,129  0,073  Skin whitener
0,073  0,018  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,115  0,061  GABA receptor agonist
0,120  0,067  Antineoplastic antimetabolite
0,138  0,086  Acetylcholine M1 receptor antagonist
0,165  0,113  Antihypertriglyceridemic
0,081  0,029  Beta tubulin antagonist
0,191  0,141  Cardioprotectant
0,175  0,126  Antineoplastic (non-small cell lung cancer)
0,093  0,045  GABA A receptor agonist
0,064  0,019  Anesthetic inhalation
0,128  0,085  Protein kinase stimulant
0,067  0,027  GABA receptor antagonist
0,043  0,004  Hedgehog signaling activator
0,128  0,093  Skeletal muscle relaxant
0,039  0,004  Progesterone receptor B antagonist
0,052  0,017  Liver X receptor alpha agonist
0,102  0,068  Topoisomerase I inhibitor
0,122  0,089  Cachexia treatment
0,121  0,090  Antineoplastic (squamous cell carcinoma)
0,110  0,080  Transcription factor STAT6 inhibitor
0,066  0,037  Antimycoplasmal
0,060  0,031  GABA A receptor antagonist
0,051  0,022  Liver X receptor agonist
0,057  0,028  Glucose-6-phosphate translocase inhibitor
0,114  0,087  Retinoprotector
0,107  0,079  Topoisomerase II inhibitor
0,154  0,130  Antiulcerative
0,024  0,002  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,243  0,221  Antidiabetic
0,243  0,221  Cyclophilin D inhibitor
0,054  0,036  Alpha tubulin antagonist
0,042  0,024  Cholesterol absorption inhibitor
0,071  0,054  CDC25A inhibitor
0,130  0,113  Male reproductive disfunction treatment
0,021  0,006  Telomerase stimulant
0,100  0,087  Acetylcholine release stimulant
0,019  0,008  Vitamin D receptor agonist
0,023  0,013  Vitamin D receptor antagonist
0,152  0,143  Free radical scavenger
0,080  0,071  Transcription factor NF kappa B stimulant
0,148  0,140  CYP2B6 inhibitor
0,044  0,036  Microtubule stabilization
0,117  0,113  SULT1A3 substrate
0,100  0,096  Neutropenia treatment
0,181  0,179  Metabolic disease treatment
0,030  0,029  Liver X receptor beta agonist

